E. Davis - 07 Mar 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role: EVP-Gen. Diagnostics/CEO Elect
Signature: /s/ William J. O'Shaughnessy, Jr., attorney-in-fact for James E. Davis
Issuer symbol: DGX
Transactions as of: 07 Mar 2022
Transactions value $: $1,239,237
Form type: 4
Filing time: 09 Mar 2022, 15:36:35 UTC
Previous filing: 28 Feb 2022
Next filing: 03 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DGX	Common Stock	Award	$2.58M	+19.9K	+34.66%	$130.09	77.1K	07 Mar 2022	Direct	F1
transaction	DGX	Common Stock	Tax liability	-$1.34M	-10.3K	-13.39%	$130.09	66.8K	07 Mar 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).
F2	Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.